Suvretta Capital Management, LLC Point Biopharma Global Inc. Transaction History

Suvretta Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.72 - $9.78 $1.69 Million - $2.9 Million	296,098 Added 12.7%	2,627,000 $19.2 Million
Q3 2022 Nov 14, 2022	SELL	$7.24 - $10.31 $4.95 Million - $7.05 Million	-683,506 Reduced 22.67%	2,330,902 $18 Million
Q1 2022 May 16, 2022	BUY	$5.46 - $8.13 $1.86 Million - $2.78 Million	341,545 Added 12.78%	3,014,408 $24 Million
Q4 2021 Feb 14, 2022	BUY	$4.83 - $9.75 $2.16 Million - $4.37 Million	447,863 Added 20.13%	2,672,863 $15 Million
Q3 2021 Nov 15, 2021	BUY	$7.42 - $11.26 $16.5 Million - $25.1 Million	2,225,000 New	2,225,000 $17.1 Million

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.